Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
Yao, James, Chan, Jennifer A, Mita, Alain, Kundu, Madan G, Hermosillo Reséndiz, Karina, Hu, Ke, Ravichandran, Shoba, Strosberg, Jonathan, Wolin, Edward M.Volume:
Volume 10
Language:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S128547
Date:
June, 2017
File:
PDF, 1.53 MB
english, 2017